TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ).
Alembic Pharmaceuticals Limited held its 15th Annual General Meeting on August 5, 2025, via video conferencing, adhering to the regulations set by the Companies Act, 2013, and SEBI Listing Regulations, 2015. The meeting, attended by all directors and key auditors, facilitated electronic voting for resolutions and included a statement from the Chairman & CEO, Mr. Chirayu Amin, who addressed company affairs and responded to member inquiries.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its extensive range of generic formulations and active pharmaceutical ingredients, serving both domestic and international markets.
Average Trading Volume: 29,210
Technical Sentiment Signal: Strong Buy
Current Market Cap: 188.3B INR
See more data about APLLTD stock on TipRanks’ Stock Analysis page.